2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad: 1st international conference held in San Francisco, CA, May 2012, and 2nd international conference held in Indianapolis, IN, May 2013

Mary Jane De Souza, Aurelia Nattiv, Elizabeth Joy, Madhusmita Misra, Nancy I. Williams, Rebecca J. Mallinson, Jenna C. Gibbs, Marion Olmsted, Marci Goolsby, Gordon Matheson

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.

Original languageEnglish (US)
Pages (from-to)96-119
Number of pages24
JournalClinical Journal of Sport Medicine
Volume24
Issue number2
DOIs
StatePublished - Mar 1 2014

Fingerprint

Female Athlete Triad Syndrome
San Francisco
Consensus
Physicians
Sports
Therapeutics
Guidelines
Sports Medicine
Medical Societies
Amenorrhea
Contracts
Athletes
Health Personnel
Bone Density
Osteoporosis
Return to Sport
Decision Making
Eating
Research Personnel
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

@article{e5e396755ad5466f87c0a0f6bac77799,
title = "2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad: 1st international conference held in San Francisco, CA, May 2012, and 2nd international conference held in Indianapolis, IN, May 2013",
abstract = "The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.",
author = "{De Souza}, {Mary Jane} and Aurelia Nattiv and Elizabeth Joy and Madhusmita Misra and Williams, {Nancy I.} and Mallinson, {Rebecca J.} and Gibbs, {Jenna C.} and Marion Olmsted and Marci Goolsby and Gordon Matheson",
year = "2014",
month = "3",
day = "1",
doi = "10.1097/JSM.0000000000000085",
language = "English (US)",
volume = "24",
pages = "96--119",
journal = "Clinical Journal of Sport Medicine",
issn = "1050-642X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - 2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad

T2 - 1st international conference held in San Francisco, CA, May 2012, and 2nd international conference held in Indianapolis, IN, May 2013

AU - De Souza, Mary Jane

AU - Nattiv, Aurelia

AU - Joy, Elizabeth

AU - Misra, Madhusmita

AU - Williams, Nancy I.

AU - Mallinson, Rebecca J.

AU - Gibbs, Jenna C.

AU - Olmsted, Marion

AU - Goolsby, Marci

AU - Matheson, Gordon

PY - 2014/3/1

Y1 - 2014/3/1

N2 - The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.

AB - The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. Female athletes often present with 1 or more of the 3 Triad components, and an early intervention is essential to prevent its progression to serious endpoints that include clinical eating disorders, amenorrhea, and osteoporosis. This consensus statement represents a set of recommendations developed following the first (San Francisco, California) and second (Indianapolis, Indianna) International Symposia on the Female Athlete Triad. It is intended to provide clinical guidelines for physicians, athletic trainers, and other health care providers for the screening, diagnosis, and treatment of the Female Athlete Triad and to provide clear recommendations for return to play. The 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad Expert Panel has proposed a risk stratification point system that takes into account magnitude of risk to assist the physician in decision-making regarding sport participation, clearance, and return to play. Guidelines are offered for clearance categories, management by a multidisciplinary team, and implementation of treatment contracts. This consensus paper has been endorsed by The Female Athlete Triad Coalition, an International Consortium of leading Triad researchers, physicians, and other health care professionals, the American College of Sports Medicine, and the American Medical Society for Sports Medicine.

UR - http://www.scopus.com/inward/record.url?scp=84896718155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896718155&partnerID=8YFLogxK

U2 - 10.1097/JSM.0000000000000085

DO - 10.1097/JSM.0000000000000085

M3 - Article

C2 - 24569429

AN - SCOPUS:84896718155

VL - 24

SP - 96

EP - 119

JO - Clinical Journal of Sport Medicine

JF - Clinical Journal of Sport Medicine

SN - 1050-642X

IS - 2

ER -